Join
Live feed
·
INSIDERFilingvia Quantisnow
Praxis Precision Medicines Inc. logo

Director Mitchell Dean J was granted 1,371 shares, increasing direct ownership by 8% to 18,622 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PRAX· Praxis Precision Medicines Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRAX (Praxis Precision Medicines Inc.) and more on Quantisnow.